Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Scientists have found an alarming environmental impact of vast data centers - 2Aid sent by ambulance to Ukraine front line
- 3An Artemis 2 astronaut took a 'bath' on camera on the way to the moon. Mission Control's reaction was priceless (video)
- 4The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- 5EU delays signing of Mercosur free trade deal
- New findings suggest atmosphere could exist on exoplanet TOI-561b
- Reports: Germany plans expansion of foreign intelligence powers
- Without evidence, CDC changes messaging on vaccines and autism
- Audits of Espresso Types: Which Mix Is for You?
- The most effective method to Guarantee Thorough Inclusion in Senior Protection.
- Benihana is 60 years old. Gen Z is lining up.
- German journalists' union condemns attack on reporters in village
- Passenger Missing After Going Overboard Disney Cruise Ship
- New subclade K flu strain raises concerns: What families should know
